FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3010803877> ?p ?o ?g. }

• W3010803877 endingPage "30" @default.
• W3010803877 startingPage "13" @default.
• W3010803877 abstract "In this study, a system for oral delivery of oxaliplatin (OXA) was prepared for metronomic chemotherapy to enhance antitumor efficacy and modulate tumor immunity. OXA was complexed with Nα-deoxycholyl-l-lysyl-methylester (DCK) (OXA/DCK) and formulated as a nanoemulsion (OXA/DCK-NE). OXA/DCK-NE showed 3.35-fold increased permeability across a Caco-2 cell monolayer, resulting in 1.73-fold higher oral bioavailability than free OXA. In addition, treatment of the B16F10.OVA cell line with OXA/DCK-NE resulted in successful upregulation of immunogenic cell death (ICD) markers both in vitro and in vivo. In a B16F10.OVA tumor-bearing mouse model, treatment with OXA/DCK-NE substantially impeded tumor growth by 63.9 ± 13.3% compared to the control group, which was also greater than the intravenous (IV) OXA group. Moreover, treatment with a combination of oral OXA/DCK-NE and anti-programmed cell death protein-1 (αPD-1) antibody resulted in 78.3 ± 9.67% greater inhibition compared to controls. More important, OXA/DCK-NE alone had immunomodulatory effects, such as enhancement of tumor antigen uptake, activation of dendritic cells in tumor-draining lymph nodes, and augmentation of both the population and function of immune effector cells in tumor tissue as well as in the spleen; no such effects were seen in the OXA IV group. These observations provide a rationale for combining oral metronomic OXA with immunotherapy to elicit synergistic antitumor effects." @default.
• W3010803877 created "2020-03-23" @default.
• W3010803877 creator A5007381899 @default.
• W3010803877 creator A5011931629 @default.
• W3010803877 creator A5014381643 @default.
• W3010803877 creator A5032796168 @default.
• W3010803877 creator A5039462986 @default.
• W3010803877 creator A5045452301 @default.
• W3010803877 creator A5055565584 @default.
• W3010803877 creator A5068500755 @default.
• W3010803877 creator A5071684219 @default.
• W3010803877 creator A5080134916 @default.
• W3010803877 creator A5080410535 @default.
• W3010803877 date "2020-06-01" @default.
• W3010803877 modified "2023-10-14" @default.
• W3010803877 title "Modulating tumor immunity by metronomic dosing of oxaliplatin incorporated in multiple oral nanoemulsion" @default.
• W3010803877 cites W1254987090 @default.
• W3010803877 cites W1480342889 @default.
• W3010803877 cites W1540592014 @default.
• W3010803877 cites W1545264161 @default.
• W3010803877 cites W1844725082 @default.
• W3010803877 cites W1853976744 @default.
• W3010803877 cites W1867886516 @default.
• W3010803877 cites W1954350862 @default.
• W3010803877 cites W1965130745 @default.
• W3010803877 cites W1973091654 @default.
• W3010803877 cites W1974626573 @default.
• W3010803877 cites W1984345984 @default.
• W3010803877 cites W1993984872 @default.
• W3010803877 cites W1995980656 @default.
• W3010803877 cites W1997866024 @default.
• W3010803877 cites W1998074965 @default.
• W3010803877 cites W2007315311 @default.
• W3010803877 cites W2016612145 @default.
• W3010803877 cites W2019275209 @default.
• W3010803877 cites W2027298131 @default.
• W3010803877 cites W2029883816 @default.
• W3010803877 cites W2030691662 @default.
• W3010803877 cites W2032101943 @default.
• W3010803877 cites W2032222317 @default.
• W3010803877 cites W2041459926 @default.
• W3010803877 cites W2042819483 @default.
• W3010803877 cites W2043442041 @default.
• W3010803877 cites W2047902191 @default.
• W3010803877 cites W2049875108 @default.
• W3010803877 cites W2052551388 @default.
• W3010803877 cites W2059294866 @default.
• W3010803877 cites W2059428912 @default.
• W3010803877 cites W2062601742 @default.
• W3010803877 cites W2068036279 @default.
• W3010803877 cites W2070025581 @default.
• W3010803877 cites W2070396908 @default.
• W3010803877 cites W2071069178 @default.
• W3010803877 cites W2078128477 @default.
• W3010803877 cites W2078448383 @default.
• W3010803877 cites W2091103707 @default.
• W3010803877 cites W2093424661 @default.
• W3010803877 cites W2095105313 @default.
• W3010803877 cites W2096539359 @default.
• W3010803877 cites W2098414192 @default.
• W3010803877 cites W2106949373 @default.
• W3010803877 cites W2108249518 @default.
• W3010803877 cites W2108571956 @default.
• W3010803877 cites W2108613911 @default.
• W3010803877 cites W2111415894 @default.
• W3010803877 cites W2120426523 @default.
• W3010803877 cites W2125821230 @default.
• W3010803877 cites W2130153302 @default.
• W3010803877 cites W2130177169 @default.
• W3010803877 cites W2134354994 @default.
• W3010803877 cites W2136859769 @default.
• W3010803877 cites W2137049683 @default.
• W3010803877 cites W2147259528 @default.
• W3010803877 cites W2155599713 @default.
• W3010803877 cites W2160410413 @default.
• W3010803877 cites W2161714684 @default.
• W3010803877 cites W2172268423 @default.
• W3010803877 cites W2316224242 @default.
• W3010803877 cites W2558830623 @default.
• W3010803877 cites W2586435368 @default.
• W3010803877 cites W2586843734 @default.
• W3010803877 cites W2614880284 @default.
• W3010803877 cites W2619094261 @default.
• W3010803877 cites W2756059240 @default.
• W3010803877 cites W2756279299 @default.
• W3010803877 cites W2761946249 @default.
• W3010803877 cites W2766379617 @default.
• W3010803877 cites W2767210366 @default.
• W3010803877 cites W2783674580 @default.
• W3010803877 cites W2785827727 @default.
• W3010803877 cites W2802731336 @default.
• W3010803877 cites W2804842145 @default.
• W3010803877 cites W2805794205 @default.
• W3010803877 cites W2807209520 @default.
• W3010803877 cites W2888059202 @default.
• W3010803877 cites W2889823397 @default.
• W3010803877 cites W2895934010 @default.
• W3010803877 cites W2960165302 @default.

• next